BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdou AG, Eldien MM, Elsakka D. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas. Int J Surg Pathol 2015;23:447-53. [PMID: 26092229 DOI: 10.1177/1066896915589968] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zuo J, Wen J, Lei M, Wen M, Li S, Lv X, Luo Z, Wen G. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT. Med Oncol 2016;33:15. [PMID: 26749588 DOI: 10.1007/s12032-015-0716-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
2 Campos TPRD, Dalmazio I, Augusti R, Almeida IG. Gd-GLU toward NMR imaging: synthesis, characterization and breast cell uptake assay. Braz J Pharm Sci 2020;56:e18122. [DOI: 10.1590/s2175-97902019000318122] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Manzano CM, Nakahata DH, de Paiva RE. Revisiting metallodrugs for the treatment of skin cancers. Coordination Chemistry Reviews 2022;462:214506. [DOI: 10.1016/j.ccr.2022.214506] [Reference Citation Analysis]
4 Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Uehara J, Ishida Y, Otsuka A, Hirata K, Shimizu H. Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma. J Eur Acad Dermatol Venereol 2018;32:e285-7. [PMID: 29377285 DOI: 10.1111/jdv.14821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Mahajan S, Barker CA, Singh B, Pandit-Taskar N. Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma. Nucl Med Commun 2019;40:744-51. [PMID: 31095044 DOI: 10.1097/MNM.0000000000001029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Hasan Ali O, Diem S, Aschwanden J, Markert E, Tasman AJ, Mueller J, Flatz L. GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography. JAAD Case Rep 2016;2:415-7. [PMID: 27766306 DOI: 10.1016/j.jdcr.2016.08.011] [Reference Citation Analysis]
7 Sánchez-Romero C, Bologna-Molina R, Mosqueda-Taylor A, Paes de Almeida O. Immunohistochemical Expression of GLUT-1 and HIF-1α in Tooth Germ, Ameloblastoma, and Ameloblastic Carcinoma. Int J Surg Pathol 2016;24:410-8. [PMID: 27020375 DOI: 10.1177/1066896916640359] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Su J, Gao T, Jiang M, Wu L, Zeng W, Zhao S, Peng C, Chen X. CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma. Oncotarget 2016;7:64778-84. [PMID: 27556188 DOI: 10.18632/oncotarget.11415] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
9 Dash KC, Bandyopadhyay A, Panda A, Behura SS, Ramachandra S, Mishra P. Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study. The Journal of Contemporary Dental Practice 2017;18:366-70. [DOI: 10.5005/jp-journals-10024-2048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Alaeddini M, Etemad-Moghadam S. Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck. Braz J Otorhinolaryngol 2020:S1808-8694(20)30140-3. [PMID: 32972865 DOI: 10.1016/j.bjorl.2020.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Morais M, Dias F, Teixeira AL, Medeiros R. MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers. Biochim Biophys Acta Gen Subj 2017;1861:2175-85. [PMID: 28579513 DOI: 10.1016/j.bbagen.2017.05.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
12 Che K, Han W, Li D, Cui S, Zhang M, Yang X, Niu H. Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma. Biosci Rep 2021;41:BSR20203982. [PMID: 33558879 DOI: 10.1042/BSR20203982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zambrano A, Molt M, Uribe E, Salas M. Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy. Int J Mol Sci 2019;20:E3374. [PMID: 31324056 DOI: 10.3390/ijms20133374] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
14 Cao S, Chen Y, Ren Y, Feng Y, Long S. GLUT1 biological function and inhibition: research advances. Future Med Chem 2021;13:1227-43. [PMID: 34018847 DOI: 10.4155/fmc-2021-0071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Shou H, Yasuo Y, Yuan S, Lou H, Ni J. Association of pretreatment SUVmax of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis. Int J Gynaecol Obstet 2021;152:112-7. [PMID: 33141954 DOI: 10.1002/ijgo.13465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]